One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: The e-BioMatrix multicenter post marketing surveillance registry in India-Reference-Cited by-同舟云学术

One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: The e-BioMatrix multicenter post marketing surveillance registry in India

Published:2013-09 Issue:5 Volume:65 Page:593-599
ISSN:0019-4832
Container-title:Indian Heart Journal
language:en
Short-container-title:Indian Heart Journal

Author:

Mehta Ashwin B.,Chandra Praveen,Dalal Jamshed,Shetty Prabhakar,Desai Devang,Chocklingam K.,Prajapati Jayesh,Kumar Pramod,Magarkar Vilas,Vasawada Apurva,Goyal B.K.,Kumar Viveka,Rao V. Suryaprakash,Babu Ramesh,Parikh Pritesh,Kaul Upendra,Patil Aruna,Mhetre Tushar,Rangnekar Hrishikesh

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization;Morice;N Engl J Med,2002

2. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

3. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS);Schofer;Lancet,2003

4. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS);Schampaert;J Am Coll Cardiol,2004

5. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial;Ardissino;JAMA,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends;Bioactive Materials;2023-05

2. Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents;Frontiers in Pharmacology;2022-11-16

3. The Biolimus Stent Family;Interventional Cardiology;2022-05-06

4. Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach;Journal of Cardiothoracic Surgery;2022-04-04

5. Assessment of utility values and QALYs after primary PCI with DP-Xience and BP-Biomatrix stents;PLOS ONE;2021-06-17